Skip to content

We need the Patent Pool to work

The exorbitant price of AIDS medicines, especially antiretrovirals, has been one of the main barriers to people with HIV accessing them, especially in developing countries. As activist organisations we have been at the forefront of many of the struggles to make medicines affordable.
Read more

What We Need to Cure AIDS?

By Mark Harrington A cure for HIV is possible: one man, the so-called Berlin patient, has already been cured of chronic HIV infection with an immune system transplant with cells genetically resistant to HIV. After four years, the man remains…

Read more

Cure Research Momentum Accelerates

By Richard Jefferys The research effort to discover a cure for HIV infection continues to gain momentum, with several important developments having occurred since the last issue of TAGline. In July, the National Institute of Allergy and Infectious Diseases (NIAID)…

Read more
PDF icon

A Golden Decade of Antiretroviral Drug Development

Success rate for new ARVs entering phases II–III surpassed 32% from 2003–2011 U.S. ADAP Prescribing Practices Closely Match Recent ARV Guidelines by Polly Clayden and Mark Harrington As we were putting together the 2011 Pipeline Report this summer, we decided…

Read more

TAG Goes to Cuba

by Coco Jervis Cuba boasts model health outcomes but at what costs to human rights? In November 2009 TAG’s senior policy associate, Coco Jervis, attended the Global Forum for Health Research meeting in Havana, Cuba, under a special license that…

Read more
Back To Top